The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion

Markku S. Nieminen(Cornell University), Piero Pollesello(Orion Corporation (Finland)), Finn Gustafsson(University of Copenhagen), Alejandro Recio‐Mayoral(Hospital Universitario Virgen Macarena), Giancarlo Marenzi(Centro Cardiologico Monzino), Sundeep Kaul(National Health Service), Charles Gibson(Royal Devon & Exeter NHS Foundation Trust), Matti Kivikko, Susana Costa(University of Coimbra), Pentti Põder, С.Т. Мацкеплишвили(Lomonosov Moscow State University), Kristjan Karason(Sahlgrenska University Hospital), Vojka Gorjup(Ljubljana University Medical Centre), Bohdan Nessler(Jagiellonian University), Josep Masip, István Édes(University of Debrecen), Richard Rokyta(Charles University), Endre Zima(Semmelweis University), Fabio Guarracino(Azienda Ospedaliera Universitaria Pisana), Michael Buerke(St. Marien Hospital), Steffen Rex(KU Leuven), Igor Katsytadze(Kyiv City Clinical Oncology Center), Alain Cohen‐Solal(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), А. Д. Эрлих(Federal Research and Clinical Center of Physical-Chemical Medicine named after Y.M. Lopukhin), Jacob Eifer Møller(University of Southern Denmark), Fabrizio Oliva(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Veli-Pekka Harjola(University of Helsinki), Fátima Franco(University of Coimbra), Argyrios Ntalianis(Alexandra Hospital), Trygve Husebye(Oslo University Hospital), Jadwiga Nessler(Jagiellonian University), Ruth H. Strasser(University Hospital Carl Gustav Carus), Emel Pichler-Cetin(Klinik Hietzing)
International Journal of Cardiology
May 14, 2016
10.1016/j.ijcard.2016.05.009
Cited by 83

Related Papers

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k